메뉴 건너뛰기




Volumn 34, Issue 11, 2016, Pages 1270-1277

Improved method to stratify elderly patients with cancer at risk for competing events

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; FEMALE; GERIATRIC PATIENT; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SECOND CANCER; BREAST TUMOR; CANCER REGISTRY; CAUSE OF DEATH; COMPARATIVE STUDY; COMPLICATION; EPIDEMIOLOGY; HEAD AND NECK TUMOR; MEDICARE; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; RISK FACTOR; STATISTICAL MODEL; UNITED STATES; VERY ELDERLY;

EID: 84963577001     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.0739     Document Type: Article
Times cited : (57)

References (42)
  • 1
    • 50549102861 scopus 로고    scopus 로고
    • Choice and interpretation of statistical tests used when competing risks are present
    • Dignam JJ, Kocherginsky MN: Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26:4027-4034, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 4027-4034
    • Dignam, J.J.1    Kocherginsky, M.N.2
  • 2
    • 78049445066 scopus 로고    scopus 로고
    • Pitfalls of using composite primary end points in the presence of competing risks
    • Mell LK, Jeong JH: Pitfalls of using composite primary end points in the presence of competing risks. J Clin Oncol 28:4297-4299, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 4297-4299
    • Mell, L.K.1    Jeong, J.H.2
  • 3
    • 73949129781 scopus 로고    scopus 로고
    • Predictors of competing mortality in advanced head and neck cancer
    • Mell LK, Dignam JJ, Salama JK, et al: Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28:15-20, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 15-20
    • Mell, L.K.1    Dignam, J.J.2    Salama, J.K.3
  • 4
    • 80052981071 scopus 로고    scopus 로고
    • Populationbased study of competing mortality in head and neck cancer
    • Rose BS, Jeong JH, Nath SK, et al: Populationbased study of competing mortality in head and neck cancer. J Clin Oncol 29:3503-3509, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 3503-3509
    • Rose, B.S.1    Jeong, J.H.2    Nath, S.K.3
  • 5
    • 36348959692 scopus 로고    scopus 로고
    • More on cetuximab in head and neck cancer
    • author reply 2202-2203
    • Mell LK, Weichselbaum RR: More on cetuximab in head and neck cancer. N Engl J Med 357: 2201-2202, 2007; author reply 2202-2203
    • (2007) N Engl J Med , vol.357 , pp. 2201-2202
    • Mell, L.K.1    Weichselbaum, R.R.2
  • 6
    • 1642382955 scopus 로고    scopus 로고
    • Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy
    • Argiris A, Brockstein BE, Haraf DJ, et al: Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10:1956-1962, 2004
    • (2004) Clin Cancer Res , vol.10 , pp. 1956-1962
    • Argiris, A.1    Brockstein, B.E.2    Haraf, D.J.3
  • 7
    • 84869385274 scopus 로고    scopus 로고
    • Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study
    • Taghipour S, Banjevic D, Fernandes J, et al: Predictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study. BMC Cancer 12:299, 2012
    • (2012) BMC Cancer , vol.12 , pp. 299
    • Taghipour, S.1    Banjevic, D.2    Fernandes, J.3
  • 8
    • 84903120366 scopus 로고    scopus 로고
    • Validated competing event model for the stage I-II endometrial cancer population
    • Carmona R, Gulaya S, Murphy JD, et al: Validated competing event model for the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys 89:888-898, 2014
    • (2014) Int J Radiat Oncol Biol Phys , vol.89 , pp. 888-898
    • Carmona, R.1    Gulaya, S.2    Murphy, J.D.3
  • 11
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistribution of a competing risk
    • Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Fine, J.P.1    Gray, R.J.2
  • 12
    • 33846855572 scopus 로고    scopus 로고
    • Cumulative incidence in competing risks data and competing risks regression analysis
    • Kim HT: Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 13:559-565, 2007
    • (2007) Clin Cancer Res , vol.13 , pp. 559-565
    • Kim, H.T.1
  • 13
    • 84859842971 scopus 로고    scopus 로고
    • The use and interpretation of competing risks regression models
    • Dignam JJ, Zhang Q, Kocherginsky M: The use and interpretation of competing risks regression models. Clin Cancer Res 18:2301-2308, 2012
    • (2012) Clin Cancer Res , vol.18 , pp. 2301-2308
    • Dignam, J.J.1    Zhang, Q.2    Kocherginsky, M.3
  • 14
    • 0034531923 scopus 로고    scopus 로고
    • Development of a comorbidity index using physician claims data
    • Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
    • (2000) J Clin Epidemiol , vol.53 , pp. 1258-1267
    • Klabunde, C.N.1    Potosky, A.L.2    Legler, J.M.3
  • 15
    • 0026562206 scopus 로고
    • Applications of crude incidence curves
    • Korn EL, Dorey FJ: Applications of crude incidence curves. Stat Med 11:813-829, 1992
    • (1992) Stat Med , vol.11 , pp. 813-829
    • Korn, E.L.1    Dorey, F.J.2
  • 16
    • 21144484803 scopus 로고
    • On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data
    • Gaynor JJ, Feuer EJ, Tan CC, et al: On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Stat Assoc 88:400-409, 1993
    • (1993) J Am Stat Assoc , vol.88 , pp. 400-409
    • Gaynor, J.J.1    Feuer, E.J.2    Tan, C.C.3
  • 17
    • 78650039392 scopus 로고    scopus 로고
    • Time-dependent predictive accuracy in the presence of competing risks
    • Saha P, Heagerty PJ: Time-dependent predictive accuracy in the presence of competing risks. Biometrics 66:999-1011, 2010
    • (2010) Biometrics , vol.66 , pp. 999-1011
    • Saha, P.1    Heagerty, P.J.2
  • 18
    • 34548575455 scopus 로고    scopus 로고
    • Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification
    • Kent DM, Hayward RA: Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification. JAMA 298:1209-1212, 2007
    • (2007) JAMA , vol.298 , pp. 1209-1212
    • Kent, D.M.1    Hayward, R.A.2
  • 19
    • 84930754128 scopus 로고    scopus 로고
    • Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer
    • Zakeri K, Rose BS, D'Amico AV, et al: Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol 115:114-119, 2015
    • (2015) Radiother Oncol , vol.115 , pp. 114-119
    • Zakeri, K.1    Rose, B.S.2    D'Amico, A.V.3
  • 20
    • 84884908099 scopus 로고    scopus 로고
    • Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and earlystage prostate cancer
    • Daskivich TJ, Chamie K, Kwan L, et al: Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and earlystage prostate cancer. Cancer 119:3446-3453, 2013
    • (2013) Cancer , vol.119 , pp. 3446-3453
    • Daskivich, T.J.1    Chamie, K.2    Kwan, L.3
  • 21
    • 67449110637 scopus 로고    scopus 로고
    • Survivorship beyond convalescence: 48-Month quality-of-life outcomes after treatment for localized prostate cancer
    • Gore JL, Kwan L, Lee SP, et al: Survivorship beyond convalescence: 48-Month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst 101:888-892, 2009
    • (2009) J Natl Cancer Inst , vol.101 , pp. 888-892
    • Gore, J.L.1    Kwan, L.2    Lee, S.P.3
  • 22
    • 0034685027 scopus 로고    scopus 로고
    • Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study
    • Stanford JL, Feng Z, Hamilton AS, et al: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283:354-360, 2000
    • (2000) JAMA , vol.283 , pp. 354-360
    • Stanford, J.L.1    Feng, Z.2    Hamilton, A.S.3
  • 23
    • 84878059899 scopus 로고    scopus 로고
    • Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. Population-based cohort of men with prostate cancer
    • Daskivich TJ, Fan KH, Koyama T, et al: Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 158:709-717, 2013
    • (2013) Ann Intern Med , vol.158 , pp. 709-717
    • Daskivich, T.J.1    Fan, K.H.2    Koyama, T.3
  • 24
    • 79955705831 scopus 로고    scopus 로고
    • Radical prostatectomy versus watchful waiting in early prostate cancer
    • SPCG-4 Investigators
    • Bill-Axelson A, Holmberg L, Ruutu M, et al; SPCG-4 Investigators: Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364:1708-1717, 2011
    • (2011) N Engl J Med , vol.364 , pp. 1708-1717
    • Bill-Axelson, A.1    Holmberg, L.2    Ruutu, M.3
  • 25
    • 79955495412 scopus 로고    scopus 로고
    • Overtreatment of men with low-risk prostate cancer and significant comorbidity
    • Daskivich TJ, Chamie K, Kwan L, et al: Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer 117:2058-2066, 2011
    • (2011) Cancer , vol.117 , pp. 2058-2066
    • Daskivich, T.J.1    Chamie, K.2    Kwan, L.3
  • 26
    • 77952787905 scopus 로고    scopus 로고
    • Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients
    • Datema FR, Ferrier MB, Van Der Schroeff MP, et al: Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 32:728-736, 2010
    • (2010) Head Neck , vol.32 , pp. 728-736
    • Datema, F.R.1    Ferrier, M.B.2    Van Der Schroeff, M.P.3
  • 27
    • 84903897547 scopus 로고    scopus 로고
    • Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer
    • Kwon M, Roh JL, Song J, et al: Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer. AnnOncol 25: 1208-1214, 2014
    • (2014) AnnOncol , vol.25 , pp. 1208-1214
    • Kwon, M.1    Roh, J.L.2    Song, J.3
  • 28
    • 77955450647 scopus 로고    scopus 로고
    • Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy
    • (Phila)
    • Yi M, Hunt KK, Arun BK, et al: Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila) 3:1026-1034, 2010
    • (2010) Cancer Prev Res , vol.3 , pp. 1026-1034
    • Yi, M.1    Hunt, K.K.2    Arun, B.K.3
  • 29
    • 78649614779 scopus 로고    scopus 로고
    • Predictors of competing mortality in early breast cancer
    • Mell LK, Jeong JH, Nichols MA, et al: Predictors of competing mortality in early breast cancer. Cancer 116:5365-5373, 2010
    • (2010) Cancer , vol.116 , pp. 5365-5373
    • Mell, L.K.1    Jeong, J.H.2    Nichols, M.A.3
  • 30
    • 60549084893 scopus 로고    scopus 로고
    • Competing risks to breast cancer mortality in Catalonia
    • Vilaprinyo E, Gispert R, Martínez-Alonso M, et al: Competing risks to breast cancer mortality in Catalonia. BMC Cancer 8:331, 2008
    • (2008) BMC Cancer , vol.8 , pp. 331
    • Vilaprinyo, E.1    Gispert, R.2    Martínez-Alonso, M.3
  • 32
    • 2442696436 scopus 로고    scopus 로고
    • Prognostic importance of comorbidity in a hospitalbased cancer registry
    • Piccirillo JF, Tierney RM, Costas I, et al: Prognostic importance of comorbidity in a hospitalbased cancer registry. JAMA 291:2441-2447, 2004
    • (2004) JAMA , vol.291 , pp. 2441-2447
    • Piccirillo, J.F.1    Tierney, R.M.2    Costas, I.3
  • 34
    • 77954775138 scopus 로고    scopus 로고
    • Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease
    • Lund JL, Harlan LC, Yabroff KR, et al: Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease. Cancer Invest 28: 758-764, 2010
    • (2010) Cancer Invest , vol.28 , pp. 758-764
    • Lund, J.L.1    Harlan, L.C.2    Yabroff, K.R.3
  • 35
    • 84929941498 scopus 로고    scopus 로고
    • Smoking and mortality-Beyond established causes
    • Carter BD, Abnet CC, Feskanich D, et al: Smoking and mortality-Beyond established causes. N Engl J Med 372:631-640, 2015
    • (2015) N Engl J Med , vol.372 , pp. 631-640
    • Carter, B.D.1    Abnet, C.C.2    Feskanich, D.3
  • 36
    • 77954190940 scopus 로고    scopus 로고
    • Human papillomavirus and survival of patients with oropharyngeal cancer
    • Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35, 2010
    • (2010) N Engl J Med , vol.363 , pp. 24-35
    • Ang, K.K.1    Harris, J.2    Wheeler, R.3
  • 37
    • 84923197605 scopus 로고    scopus 로고
    • Comprehensive genomic characterization of head and neck squamous cell carcinomas
    • Cancer Genome Atlas Network: Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517:576-582, 2015
    • (2015) Nature , vol.517 , pp. 576-582
  • 38
    • 84922592521 scopus 로고    scopus 로고
    • Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: A retrospective cohort study
    • Lalonde E, Ishkanian AS, Sykes J, et al: Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: A retrospective cohort study. Lancet Oncol 15:1521-1532, 2014
    • (2014) Lancet Oncol , vol.15 , pp. 1521-1532
    • Lalonde, E.1    Ishkanian, A.S.2    Sykes, J.3
  • 39
    • 0343918505 scopus 로고    scopus 로고
    • BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
    • Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336: 1409-1415, 1997
    • (1997) N Engl J Med , vol.336 , pp. 1409-1415
    • Couch, F.J.1    DeShano, M.L.2    Blackwood, M.A.3
  • 41
    • 84859817083 scopus 로고    scopus 로고
    • Risk models and patientcentered evidence: Should physicians expect one right answer?
    • Kent DM, Shah ND: Risk models and patientcentered evidence: Should physicians expect one right answer? JAMA 307:1585-1586, 2012
    • (2012) JAMA , vol.307 , pp. 1585-1586
    • Kent, D.M.1    Shah, N.D.2
  • 42
    • 84911448670 scopus 로고    scopus 로고
    • Population and personalized medicine in the modern era
    • Mega JL, Sabatine MS, Antman EM: Population and personalized medicine in the modern era. JAMA 312:1969-1970, 2014
    • (2014) JAMA , vol.312 , pp. 1969-1970
    • Mega, J.L.1    Sabatine, M.S.2    Antman, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.